Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896877797> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2896877797 abstract "The Alzheimer's Prevention Initiative (API) was established to accelerate Alzheimer's disease (AD) prevention research, forge public-private partnerships, conduct prevention trials with maximal scientific benefit, clarify biomarker roles, and share data and biological samples after trials are completed. In conjunction with the Collaboration for Alzheimer's Prevention (CAP), API also agreed to share baseline data before its trials are completed. We now report availability of baseline data and brain images from the API Autosomal Dominant AD (ADAD) Colombia Trial, a prevention trial in Presenilin 1 (PSEN1) E280A mutation carriers and non-carriers from the world's largest ADAD kindred. The API ADAD Colombia Trial is a 60-month randomized, placebo-controlled prevention trial of the investigational amyloid-β (Aβ) antibody therapy crenezumab in 252 unimpaired 30-60 year-old kindred members, including mutation carriers who were randomized to active treatment or placebo and non-carriers who receive placebo. The mutation is virtually certain to cause mild cognitive impairment (MCI) and dementia due to AD at respective the ages of 44±5 and 49±5. For ethical reasons, participants have not received their mutation test results. Florbetapir (Aβ) PET, fluorodeoxyglucose PET, and MRI scans—and CSF and blood samples in those who consent--are acquired at baseline and several follow-up visits. GTP1 (tau) PET scans are proposed at ∼months 30 and 60. The baseline data-sharing plan was developed to benefit the field while protecting participant identification and trial integrity. Several data attributes and information about how to request data will be available through the Global Alzheimer's Association Interactive Network (GAAIN). Subject-level data and images will be then shared with approved users. Other data and available biological samples will be shared after the trial is completed. We will summarize participant characteristics, our available data and data-sharing plan, and how researchers can request and receive data. The API ADAD Colombia Trial baseline data sharing program is intended to advance the study of preclinical AD, underscore the importance of data sharing in all trials, and do so in a way that protects participant identification and trial integrity." @default.
- W2896877797 created "2018-10-26" @default.
- W2896877797 creator A5002451678 @default.
- W2896877797 creator A5004794322 @default.
- W2896877797 creator A5007248632 @default.
- W2896877797 creator A5014949118 @default.
- W2896877797 creator A5019535453 @default.
- W2896877797 creator A5024744959 @default.
- W2896877797 creator A5031640722 @default.
- W2896877797 creator A5038132886 @default.
- W2896877797 creator A5039393374 @default.
- W2896877797 creator A5040374029 @default.
- W2896877797 creator A5047768726 @default.
- W2896877797 creator A5050777990 @default.
- W2896877797 creator A5055843167 @default.
- W2896877797 creator A5057723790 @default.
- W2896877797 creator A5072210516 @default.
- W2896877797 creator A5073489682 @default.
- W2896877797 creator A5074384523 @default.
- W2896877797 date "2018-07-01" @default.
- W2896877797 modified "2023-10-16" @default.
- W2896877797 title "P4‐209: A PUBLIC RESOURCE OF BASELINE DATA FROM THE API AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE COLOMBIA TRIAL" @default.
- W2896877797 doi "https://doi.org/10.1016/j.jalz.2018.07.030" @default.
- W2896877797 hasPublicationYear "2018" @default.
- W2896877797 type Work @default.
- W2896877797 sameAs 2896877797 @default.
- W2896877797 citedByCount "1" @default.
- W2896877797 countsByYear W28968777972020 @default.
- W2896877797 crossrefType "journal-article" @default.
- W2896877797 hasAuthorship W2896877797A5002451678 @default.
- W2896877797 hasAuthorship W2896877797A5004794322 @default.
- W2896877797 hasAuthorship W2896877797A5007248632 @default.
- W2896877797 hasAuthorship W2896877797A5014949118 @default.
- W2896877797 hasAuthorship W2896877797A5019535453 @default.
- W2896877797 hasAuthorship W2896877797A5024744959 @default.
- W2896877797 hasAuthorship W2896877797A5031640722 @default.
- W2896877797 hasAuthorship W2896877797A5038132886 @default.
- W2896877797 hasAuthorship W2896877797A5039393374 @default.
- W2896877797 hasAuthorship W2896877797A5040374029 @default.
- W2896877797 hasAuthorship W2896877797A5047768726 @default.
- W2896877797 hasAuthorship W2896877797A5050777990 @default.
- W2896877797 hasAuthorship W2896877797A5055843167 @default.
- W2896877797 hasAuthorship W2896877797A5057723790 @default.
- W2896877797 hasAuthorship W2896877797A5072210516 @default.
- W2896877797 hasAuthorship W2896877797A5073489682 @default.
- W2896877797 hasAuthorship W2896877797A5074384523 @default.
- W2896877797 hasConcept C126322002 @default.
- W2896877797 hasConcept C12725497 @default.
- W2896877797 hasConcept C142724271 @default.
- W2896877797 hasConcept C168563851 @default.
- W2896877797 hasConcept C175344181 @default.
- W2896877797 hasConcept C204787440 @default.
- W2896877797 hasConcept C27081682 @default.
- W2896877797 hasConcept C2776485563 @default.
- W2896877797 hasConcept C2779134260 @default.
- W2896877797 hasConcept C2779483572 @default.
- W2896877797 hasConcept C502032728 @default.
- W2896877797 hasConcept C505870484 @default.
- W2896877797 hasConcept C535046627 @default.
- W2896877797 hasConcept C71924100 @default.
- W2896877797 hasConcept C86803240 @default.
- W2896877797 hasConceptScore W2896877797C126322002 @default.
- W2896877797 hasConceptScore W2896877797C12725497 @default.
- W2896877797 hasConceptScore W2896877797C142724271 @default.
- W2896877797 hasConceptScore W2896877797C168563851 @default.
- W2896877797 hasConceptScore W2896877797C175344181 @default.
- W2896877797 hasConceptScore W2896877797C204787440 @default.
- W2896877797 hasConceptScore W2896877797C27081682 @default.
- W2896877797 hasConceptScore W2896877797C2776485563 @default.
- W2896877797 hasConceptScore W2896877797C2779134260 @default.
- W2896877797 hasConceptScore W2896877797C2779483572 @default.
- W2896877797 hasConceptScore W2896877797C502032728 @default.
- W2896877797 hasConceptScore W2896877797C505870484 @default.
- W2896877797 hasConceptScore W2896877797C535046627 @default.
- W2896877797 hasConceptScore W2896877797C71924100 @default.
- W2896877797 hasConceptScore W2896877797C86803240 @default.
- W2896877797 hasIssue "7S_Part_29" @default.
- W2896877797 hasLocation W28968777971 @default.
- W2896877797 hasOpenAccess W2896877797 @default.
- W2896877797 hasPrimaryLocation W28968777971 @default.
- W2896877797 hasRelatedWork W1974015070 @default.
- W2896877797 hasRelatedWork W2001854231 @default.
- W2896877797 hasRelatedWork W2133132878 @default.
- W2896877797 hasRelatedWork W2151288930 @default.
- W2896877797 hasRelatedWork W2169313980 @default.
- W2896877797 hasRelatedWork W2355760844 @default.
- W2896877797 hasRelatedWork W2416462336 @default.
- W2896877797 hasRelatedWork W2766902548 @default.
- W2896877797 hasRelatedWork W2801312068 @default.
- W2896877797 hasRelatedWork W2950273610 @default.
- W2896877797 hasVolume "14" @default.
- W2896877797 isParatext "false" @default.
- W2896877797 isRetracted "false" @default.
- W2896877797 magId "2896877797" @default.
- W2896877797 workType "article" @default.